Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 76–90 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3031 ASXL1 Gene Bohring-Opitz Syndrome Genetic Test This test sequences the ASXL1 gene to identify pathogenic variants associated with Bohring-Opitz syndrome.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ASXL1 gene", "Coding region coverage"] Parameters [] Preparation ["No fasting required", "No medication changes required unless directed by doctor", "Pre-test genetic counselling session mandatory"] Indications ["Clinical suspicion of Bohring-Opitz syndrome", "Family members where a mutation has already been identified"] Measurement technique Confirm with laboratory Codes LOINC: 76699-5 ICD-10: Q87.8, Z15.8, Z13.71 Clinical summary This test sequences the ASXL1 gene to identify pathogenic variants associated with Bohring-Opitz syndrome.
TEST-3868 ATM Gene Ataxia-Telangiectasia Genetic Test This test evaluates the ATM gene for pathogenic variants associated with Ataxia-Telangiectasia and hereditary cancer predisposition.	Peripheral Whole Blood (EDTA), FTA Card Dried Blood Spot, or Extracted DNA	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATM gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Family history of A‑T", "Symptoms suggestive of A‑T", "Early-onset breast cancer", "Hereditary cancer panel evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 90388-3 ICD-10: G11.3, Z15.09 Clinical summary This test evaluates the ATM gene for pathogenic variants associated with Ataxia-Telangiectasia and hereditary cancer predisposition.
TEST-3741 ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test This genetic test identifies pathogenic variants in the ATP1A2 gene, which are the cause of Alternating Hemiplegia of Childhood type 1.	Peripheral whole blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in ATP1A2 coding exons", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["Genetic counseling session required before testing", "Complete pedigree chart required"] Indications ["Clinical suspicion of Alternating Hemiplegia of Childhood type 1", "Family history of AHC1", "Need for definitive diagnosis to guide therapy", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 94536-9 ICD-10: G24.8 Clinical summary This genetic test identifies pathogenic variants in the ATP1A2 gene, which are the cause of Alternating Hemiplegia of Childhood type 1.
TEST-4247 ATP1A3 Gene (DYT12) Sequencing Test This test evaluates the ATP1A3 gene for pathogenic variants associated with DYT12 dystonia and alternating hemiplegia of childhood (AHC).	Whole Blood (EDTA/DNA FTA Card) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP1A3 gene sequence", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Suspected DYT12 dystonia", "Suspected alternating hemiplegia of childhood (AHC)", "Family history of DYT12 or AHC"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G24.0, G83.89 Clinical summary This test evaluates the ATP1A3 gene for pathogenic variants associated with DYT12 dystonia and alternating hemiplegia of childhood (AHC).
TEST-3937 ATP1A3 Gene CAPOS Syndrome Genetic Test This test identifies pathogenic variants within the ATP1A3 gene, providing a molecular diagnosis for CAPOS syndrome.	Whole Blood (Peripheral Venous)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATP1A3 gene"] Parameters [] Preparation [] Indications ["Suspected CAPOS syndrome", "Family history of CAPOS syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 79003-5 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants within the ATP1A3 gene, providing a molecular diagnosis for CAPOS syndrome.
TEST-3929 ATP2A1 Gene Brody Myopathy Genetic Test This test detects pathogenic mutations in the ATP2A1 gene associated with Brody myopathy.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in ATP2A1 gene coding exons and flanking intronic regions"] Parameters [] Preparation ["No fasting required"] Indications ["Confirmation of Brody myopathy diagnosis", "Forecasting disease progression", "Informing family planning through carrier detection"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G71.3 Clinical summary This test detects pathogenic mutations in the ATP2A1 gene associated with Brody myopathy.
TEST-5535 ATP6AP2 Gene (Parkinsonism with Spasticity, X-Linked) Genetic Test This test identifies pathogenic variants in the ATP6AP2 gene associated with X-linked parkinsonism and spasticity disorder.	Whole Blood (EDTA) or Saliva (Oragene DNA kit)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATP6AP2 gene", "Copy Number Variants (CNVs) in the ATP6AP2 gene"] Parameters [] Preparation ["No special preparation required.", "Patient can eat and drink normally."] Indications ["Diagnosis of X-linked parkinsonism with spasticity", "Carrier screening for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 21663-8 ICD-10: G21.22 Clinical summary This test identifies pathogenic variants in the ATP6AP2 gene associated with X-linked parkinsonism and spasticity disorder.
TEST-5814 ATP7B Gene Wilson Disease Genetic Test This genetic test identifies pathogenic variants in the ATP7B gene, confirming a diagnosis of Wilson disease.	Peripheral Whole Blood or Buccal Swab	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP7B gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected Wilson disease", "Family history of Wilson disease", "Ambiguous biochemical results", "Screening asymptomatic relatives"] Measurement technique Confirm with laboratory Codes LOINC: 94351-3 ICD-10: E83.01 Clinical summary This genetic test identifies pathogenic variants in the ATP7B gene, confirming a diagnosis of Wilson disease.
TEST-5178 ATPAF2 Gene NGS Test for Mitochondrial Complex V Deficiency (Nuclear Type 1) This test identifies pathogenic variants in the ATPAF2 gene, confirming a diagnosis of mitochondrial complex V deficiency, nuclear type 1.	Whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATPAF2 gene"] Parameters [] Preparation [] Indications ["Diagnosis of mitochondrial complex V deficiency, nuclear type 1", "Genetic counseling for affected families", "Targeted family screening", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 21615-4 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the ATPAF2 gene, confirming a diagnosis of mitochondrial complex V deficiency, nuclear type 1.
TEST-2079 ATR Gene Cutaneous Telangiectasia and Cancer Syndrome, Familial Genetic Test This genetic test identifies pathogenic variants in the ATR gene associated with increased risk for cutaneous telangiectasia and hereditary cancers.	Peripheral Whole Blood EDTA, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATR gene"] Parameters [] Preparation ["Consult referring physician regarding anticoagulants or antiplatelet medication", "Avoid heavy physical exertion and alcohol for 24 hours before the draw", "Genetic counselling session advised before sample collection"] Indications ["Individuals with a personal or family history suggestive of ATR-related conditions", "Risk assessment for hereditary cancer predisposition"] Measurement technique Confirm with laboratory Codes LOINC: 81262-7 ICD-10: Z15.09 Clinical summary This genetic test identifies pathogenic variants in the ATR gene associated with increased risk for cutaneous telangiectasia and hereditary cancers.
TEST-3630 AVPR2 Gene NSIAD Genetic Test This diagnostic test evaluates the AVPR2 gene for pathogenic variants associated with nephrogenic syndrome of inappropriate antidiuresis (NSIAD). It utilizes next-generation sequen...	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AVPR2 gene coding region", "Pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Inform doctor of all current medications"] Indications ["Suspected NSIAD", "Unexplained hyponatremia with normal adrenal/thyroid function"] Measurement technique Confirm with laboratory Codes LOINC: 91821-6 ICD-10: E22.2 Clinical summary This diagnostic test evaluates the AVPR2 gene for pathogenic variants associated with nephrogenic syndrome of inappropriate antidiuresis (NSIAD). It utilizes next-generation sequencing (NGS) for comprehensive analysis.
TEST-2266 B3GALT6 Gene Sequencing for Spondyloepimetaphyseal Dysplasia With Joint Laxity Type 1 (SEMDJL1) Test This test identifies pathogenic variants in the B3GALT6 gene associated with spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMDJL1).	Peripheral whole blood (venous), Buccal swab, or Amniotic fluid (prenatal — hospital extraction only)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B3GALT6 gene", "Deletion/duplication analysis of the B3GALT6 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Clinical suspicion of SEMDJL1", "Family history of SEMDJL1", "Need for genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 82906-6 ICD-10: Q77.8 Clinical summary This test identifies pathogenic variants in the B3GALT6 gene associated with spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMDJL1).
TEST-2515 B3GAT3 Gene Genetic Test This test identifies pathogenic variants in the B3GAT3 gene associated with linkeropathy type 2.	Whole blood (3 mL EDTA), buccal swab, or dried blood spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B3GAT3 gene", "Copy number variations (CNV) in the B3GAT3 gene"] Parameters [] Preparation ["No special preparation, including fasting, is required."] Indications ["Clinical suspicion of linkeropathy type 2", "Family history of linkeropathy type 2", "Assessment of individuals with multiple joint dislocations, short stature, craniofacial dysmorphism, or congenital heart defects"] Measurement technique Confirm with laboratory Codes LOINC: 48019-5 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants in the B3GAT3 gene associated with linkeropathy type 2.
TEST-5171 B4GAT1 Gene Muscular Dystrophy-Dystroglycanopathy Type A13 (MDDGA13) Genetic Test This genetic test identifies pathogenic mutations in the B4GAT1 gene, confirming a diagnosis of Muscular Dystrophy-Dystroglycanopathy Type A13 (MDDGA13).	Whole Blood (peripheral), Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B4GAT1 gene", "Full gene coverage including coding exons and splice sites"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% (full gene coverage including all coding exons and splice sites)"}] Preparation ["Genetic counseling with a board-certified medical geneticist is mandatory before sample collection.", "Obtain written informed consent as required under Federal Decree-Law No. 4 of 2016 on Medical Liability."] Indications ["Infants presenting with hypotonia, delayed motor milestones, structural brain defects, and ocular malformations.", "Families with a known history of MDDGA13 for carrier testing and reproductive planning."] Measurement technique Confirm with laboratory Codes LOINC: 83395-9 ICD-10: G71.0 Clinical summary This genetic test identifies pathogenic mutations in the B4GAT1 gene, confirming a diagnosis of Muscular Dystrophy-Dystroglycanopathy Type A13 (MDDGA13).
TEST-3683 B9D1 Gene Meckel Syndrome Type 9 Genetic Test This genetic test evaluates the B9D1 gene for pathogenic variants associated with Meckel syndrome type 9.	Peripheral Whole Blood (EDTA) or Saliva (Oragene DNA Kit)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B9D1 gene", "Full exon coverage of the B9D1 gene"] Parameters [{"name": "B9D1 Gene Analysis", "reference_range": "No pathogenic variants detected"}] Preparation ["No fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected Meckel syndrome type 9 based on clinical presentation", "Family history of Meckel syndrome type 9", "Prenatal diagnosis", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 56367-6 ICD-10: Q61.8 Clinical summary This genetic test evaluates the B9D1 gene for pathogenic variants associated with Meckel syndrome type 9.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.